| Worse outcomes and guideline-driven care. | |
| | |
MedLine Citation:
|
PMID: 21060022 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
|
Authors:
|
Giuseppe Famularo; Fulvio Forino; Laura Gasbarrone |
Publication Detail:
|
Type: Comment; Letter |
Journal Detail:
|
Title: Archives of neurology Volume: 67 ISSN: 1538-3687 ISO Abbreviation: Arch. Neurol. Publication Date: 2010 Nov |
Date Detail:
|
Created Date: 2010-11-09 Completed Date: 2010-12-15 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0372436 Medline TA: Arch Neurol Country: United States |
Other Details:
|
Languages: eng Pagination: 1413-4; author reply 1414 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Brain Ischemia
/
drug therapy Evidence-Based Medicine* Humans Practice Guidelines as Topic* Stroke / drug therapy Tissue Plasminogen Activator / therapeutic use Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.21.68/Tissue Plasminogen Activator |
| Comments/Corrections | |
Comment On:
|
Arch Neurol. 2010 May;67(5):559-63
[PMID:
20212195
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multiple cavernous angiomas in the brain and spinal cord.
Next Document: Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and ...